UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Clinical translation of advanced colonic drug delivery technologies

Awad, A; Madla, CM; McCoubrey, LE; Ferraro, F; Gavins, FKH; Buanz, A; Gaisford, S; ... Basit, AW; + view all (2022) Clinical translation of advanced colonic drug delivery technologies. Advanced Drug Delivery Reviews , 181 , Article 114076. 10.1016/j.addr.2021.114076. Green open access

[thumbnail of 1-s2.0-S0169409X21004695-main.pdf]
Preview
Text
1-s2.0-S0169409X21004695-main.pdf - Accepted Version

Download (6MB) | Preview

Abstract

Targeted drug delivery to the colon offers a myriad of benefits, including treatment of local diseases, direct access to unique therapeutic targets and the potential for increasing systemic drug bioavailability and efficacy. Although a range of traditional colonic delivery technologies are available, these systems exhibit inconsistent drug release due to physiological variability between and within individuals, which may be further exacerbated by underlying disease states. In recent years, significant translational and commercial advances have been made with the introduction of new technologies that incorporate multi-stimuli independent release mechanisms (pH or microbiota-dependent release). Harnessing these advanced technologies offers new possibilities for drug delivery via the colon, including the delivery of biopharmaceuticals, vaccines, nutrients, and microbiome therapeutics for treatment of both local and systemic diseases. This review details the latest advances in colonic drug delivery with an emphasis on emerging therapeutic opportunities and clinical technology translation.

Type: Article
Title: Clinical translation of advanced colonic drug delivery technologies
Location: Netherlands
Open access status: An open access version is available from UCL Discovery
DOI: 10.1016/j.addr.2021.114076
Publisher version: https://doi.org/10.1016/j.addr.2021.114076
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: 3D printing drug products, ASACOL 1600, Chronotherapy, Colonic drug targeting, Drug delivery to the large intestine, Mesalazine, OPTICORE, Phloral, Resistant starch film coatings, Ulcerative colitis and Crohn’s disease
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy > Pharmaceutics
URI: https://discovery.ucl.ac.uk/id/eprint/10140549
Downloads since deposit
675Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item